Successful hepatitis C treatment, for example, has been associated with improvements in insulin sensitivity and metabolic markers in several studies outside Africa, suggesting that treating the underlying infection may partially reverse inflammatory or hepatic mechanisms contributing to dysglycaemia [35]. Here, INS is linked to infection.